Key result
Angiographic CAD in postmenopausal women was associated with significantly decreased serum omentin 1 levels compared to those without CAD (247.5 vs 506 ng/mL, P<.001).
Why the study?
Is decreased serum omentin 1 level associated with the presence and severity of coronary artery disease in postmenopausal women?
Population
193 consecutive postmenopausal women who had undergone coronary angiography for suspected stable CAD
Comparison
Serum omentin 1 level measurement vs Patients without angiographic CAD
Design
Cross-sectional
Authors
Loading...
Supports omentin-1 as CAD biomarker candidate in postmenopausal women; leaves open causal role and clinical utility.
Cross-Sectional (n=193)
Is decreased serum omentin 1 level associated with the presence and severity of coronary artery disease in postmenopausal women?
Absolute Event Rate: 247.5% vs 506%
p-value: p=<.001
Decreased serum omentin 1 levels are independently associated with the presence and severity of angiographic coronary artery disease in postmenopausal women.
Önür et al. (2013) conducted a cross-sectional in Coronary Artery Disease (n=193). Angiographic CAD vs. No angiographic CAD (control) was evaluated on Serum omentin 1 levels (ng/mL) (p=<.001). Angiographic CAD in postmenopausal women was associated with significantly decreased serum omentin 1 levels compared to those without CAD (247.5 vs 506 ng/mL, P<.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: